The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial
Open accessAbstract
Background—: With the use of optical coherence tomography (OCT), alterations of the reflectance characteristics of everolimus-eluting bioresorbable vascular scaffold (BVS) struts have been reported in humans. In the absence of histology, the interpretation of the appearances of the struts by OCT remains speculative. We therefore report OCT findings with corresponding histology in the porcine coronary artery model immediately after and at 28 days and 2, 3, and 4 years after BVS implantation. Methods and Results—: Thirty-five polymeric BVS (3.0×12.0 mm) were singly implanted in the main coronary arteries of 17 pigs that underwent OCT and were then euthanized immediately (n=2), at 28 days (n=2), at 2 years (n=3), at 3 years (n=5), or at 4 years (n=5) after implantation. All BVS-implanted arteries in these animals were evaluated by histology except for 5 arteries examined at 2 years with gel permeation chromatography to assess the biodegradation of the polymeric device. Fourteen arteries with BVS from an additional 6 pigs were examined by gel permeation chromatography at 1 (n=1), 1.5 (n=2), and 3 (n=2) years. Corresponding OCT and histology images were selected with the distal and proximal radiopaque markers used as landmarks. At 28 days, by OCT, 82% of struts showed sharply defined, bright reflection borders, best described as a box-shaped appearance. Histologically, all struts appeared intact with no evidence of resorption. At 2 years, by OCT, 60±20 struts were discernible per BVS with 80.4% of the strut sites as a box-shaped appearance. Despite their defined appearance by OCT, by histology, these structures appeared to be composed of proteoglycan, with polymeric material being at such low level as to be no longer quantifiable by chromatography. At 3 years, by OCT, recognizable struts decreased to 28±9 struts per BVS: 43.7% showed dissolved black box; 34.8%, dissolved bright box; 16.1%, open box; and 5.4%, preserved box appearance. Histology shows that connective tissue cells within a proteoglycan-rich matrix replaced the areas previously occupied by the polymeric struts and coalesced into the arterial wall. At 4 years, by OCT, 10±6 struts were recognizable as either dissolved black or dissolved bright box. In histology, these struts are minimally discernible as foci of low-cellular-density connective tissue. Relative to the prediction of histological type by OCT appearance, the preserved box appearance of OCT corresponds well with 2-year histology (86.4%), whereas the dissolved bright and black box appearances correspond to 3-year histology (88.0% and 90.7%, respectively). Struts indiscernible by OCT correspond to the integrated strut footprints seen at 4 years (100%). Conclusions—: Struts that are still discernible by OCT at 2 years are compatible with largely bioresorbed struts, as demonstrated by histological and gel permeation chromatography analysis. At 3 and 4 years, both OCT and histology confirm complete integration of the struts into the arterial wall.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Zeger, S. L., & Liang, K.-Y. (1986) · Biometrics · doi:10.2307/2531248 · Cited by 7,764
Pathology of Drug-Eluting Stents in Humans
Joner, M., Finn, A. V., Farb, A., Mont, E. K., Kolodgie, F. D., Ladich, E., Kutys, R., Skorija, K., Gold, H. K., & Virmani, R. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.042 · Cited by 2,744
Self-citationFinn, A. V., Joner, M., Nakazawa, G., Kolodgie, F., Newell, J., John, M. C., Gold, H. K., & Virmani, R. (2007) · Circulation · doi:10.1161/circulationaha.107.693739 · Cited by 1,277
Self-citationSerruys, P. W., Ormiston, J. A., Onuma, Y., Regar, E., Gonzalo, N., Garcia-Garcia, H. M., Nieman, K., Bruining, N., Dorange, C., Miquel-Hébert, K., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60325-1 · Cited by 820
Self-citationOrmiston, J. A., Serruys, P. W., Regar, E., Dudek, D., Thuesen, L., Webster, M. W., Onuma, Y., Garcia-Garcia, H. M., McGreevy, R., & Veldhof, S. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60415-8 · Cited by 712
Self-citationIndication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
Hofma, S. H., van der Giessen, W. J., van Dalen, B. M., Lemos, P. A., McFadden, E. P., Sianos, G., Ligthart, J. M. R., van Essen, D., de Feyter, P. J., & Serruys, P. W. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi571 · Cited by 384
Self-citationSirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction
Togni, M., Windecker, S., Cocchia, R., Wenaweser, P., Cook, S., Billinger, M., Meier, B., & Hess, O. M. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.062 · Cited by 373
Biomaterial-associated calcification: pathology, mechanisms, and strategies for prevention.
Schöen, F. J., Harasaki, H., Kim, K. M., Anderson, H. C., & Levy, R. J. (1988) · PubMed · Cited by 200
Tanimoto, S., Bruining, N., van Domburg, R. T., Rotger, D., Radeva, P. I., Ligthart, J. M. R., & Serruys, P. W. J. C. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.024 · Cited by 95
Self-citationPolimeni, G., Koo, K., Pringle, G. A., Agelan, A., Safadi, F. F., & Wikesjö, U. M. E. (2007) · Clinical Implant Dentistry and Related Research · doi:10.1111/j.1708-8208.2007.00067.x · Cited by 72
Cited by
Serruys, P. W., Chevalier, B., Dudek, D., Cequier, A., Carrié, D., Iniguez, A., Dominici, M., van der Schaaf, R. J., Haude, M., Wasungu, L., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61455-0 · Cited by 564
Self-citationSerruys, P. W., Onuma, Y., Dudek, D., Smits, P. C., Koolen, J., Chevalier, B., de Bruyne, B., Thuesen, L., McClean, D., van Geuns, R.-J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.050 · Cited by 525
Self-citationOnuma, Y., & Serruys, P. W. (2011) · Circulation · doi:10.1161/circulationaha.110.971606 · Cited by 434
Self-citationYang, H., Wang, C., Liu, C., Chen, H., Wu, Y., Han, J., Jia, Z., Lin, W., Zhang, D., Li, W., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.08.022 · Cited by 399
Serruys, P. W., Onuma, Y., Ormiston, J. A., de Bruyne, B., Regar, E., Dudek, D., Thuesen, L., Smits, P. C., Chevalier, B., McClean, D., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.970772 · Cited by 307
Self-citation
Metadata
- Authors
- Onuma, Y., Serruys, P. W., Perkins, L. E. L., Okamura, T., Gonzalo, N., García-García, H. M., Regar, E., Kamberi, M., Powers, J. C., Rapoza, R., van Beusekom, H., van der Giessen, W., & Virmani, R.
- Venue
- Circulation
- Published
- 2010-11-30
- Volume
- 122
- Issue
- 22
- Pages
- 2288-2300
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2016795245
- Cited by
- 319
- References
- 14
- FWCI
- 23.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial. https://app.cochat.ai/papers/10.1161/circulationaha.109.921528
- The paper
- Onuma, Y., Serruys, P. W., Perkins, L. E. L., Okamura, T., Gonzalo, N., García-García, H. M., Regar, E., Kamberi, M., Powers, J. C., Rapoza, R., van Beusekom, H., van der Giessen, W., & Virmani, R. (2010). Intracoronary Optical Coherence Tomography and Histology at 1 Month and 2, 3, and 4 Years After Implantation of Everolimus-Eluting Bioresorbable Vascular Scaffolds in a Porcine Coronary Artery Model: An Attempt to Decipher the Human Optical Coherence Tomography Images in the ABSORB Trial. Circulation. https://doi.org/10.1161/circulationaha.109.921528
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.